IL119778A - Neuropretective pharmaceutical compositions containing rapamycin derivatives - Google Patents
Neuropretective pharmaceutical compositions containing rapamycin derivativesInfo
- Publication number
- IL119778A IL119778A IL11977896A IL11977896A IL119778A IL 119778 A IL119778 A IL 119778A IL 11977896 A IL11977896 A IL 11977896A IL 11977896 A IL11977896 A IL 11977896A IL 119778 A IL119778 A IL 119778A
- Authority
- IL
- Israel
- Prior art keywords
- neuropretective
- pharmaceutical compositions
- compositions containing
- rapamycin derivatives
- containing rapamycin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US833795P | 1995-12-07 | 1995-12-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL119778A0 IL119778A0 (en) | 1997-03-18 |
| IL119778A true IL119778A (en) | 1999-07-14 |
Family
ID=21731060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11977896A IL119778A (en) | 1995-12-07 | 1996-12-06 | Neuropretective pharmaceutical compositions containing rapamycin derivatives |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0778023B1 (no) |
| JP (1) | JPH09183727A (no) |
| KR (1) | KR970032856A (no) |
| CN (1) | CN1112925C (no) |
| AR (1) | AR008747A1 (no) |
| AT (1) | ATE234095T1 (no) |
| AU (1) | AU700653B2 (no) |
| BR (1) | BR9605895A (no) |
| CA (1) | CA2192298A1 (no) |
| CZ (2) | CZ6498A3 (no) |
| DE (1) | DE69626610T2 (no) |
| DK (1) | DK0778023T3 (no) |
| ES (1) | ES2188730T3 (no) |
| HU (1) | HUP9603370A3 (no) |
| IL (1) | IL119778A (no) |
| MX (1) | MX9606131A (no) |
| NO (1) | NO309966B1 (no) |
| NZ (1) | NZ299888A (no) |
| PT (1) | PT778023E (no) |
| SI (1) | SI0778023T1 (no) |
| SK (1) | SK154796A3 (no) |
| TW (1) | TW427904B (no) |
| ZA (1) | ZA9610245B (no) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1002535A1 (en) * | 1998-10-28 | 2000-05-24 | Hrissanthi Ikonomidou | New use of glutamate antagonists for the treatment of cancer |
| US7253169B2 (en) | 1999-11-12 | 2007-08-07 | Gliamed, Inc. | Aza compounds, pharmaceutical compositions and methods of use |
| US6417189B1 (en) * | 1999-11-12 | 2002-07-09 | Gpi Nil Holdings, Inc. | AZA compounds, pharmaceutical compositions and methods of use |
| FR2806626B1 (fr) * | 2000-03-22 | 2003-11-28 | Centre Nat Rech Scient | Utilisation de substances modulatrices de l'expression ou de la fonction d'une proteine impliquee dans le cycle cellulaire pour le traitement ou la prevention des lesions neurales aigues |
| WO2001079177A1 (en) * | 2000-04-17 | 2001-10-25 | Gpi Nil Holdings, Inc. | Cyclic diaza compounds for treating neurodegenerative disorders |
| GB0117645D0 (en) * | 2001-07-19 | 2001-09-12 | Isis Innovation | Therapeutic stratergies for prevention and treatment of alzheimers disease |
| UA78529C2 (en) * | 2001-10-10 | 2007-04-10 | Wyeth Corp | Derivatives of [[2-(amino-3,4-dioxo-1-cyclobutene-1-yl)amino]alkyl] acid for treating pain |
| US20030176455A1 (en) * | 2002-03-13 | 2003-09-18 | Wyeth | Method of inhibiting cell death |
| EP1622625A1 (en) * | 2003-04-09 | 2006-02-08 | Wyeth | Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo [5.2.o] non-1 (7)-en-2-yl )alkyl] phosphonic acid and derivatives and methods of use thereof |
| CN1863810B (zh) | 2003-04-09 | 2010-12-01 | 惠氏公司 | [2-(8，9-二氧代-2，6-二氮杂二环[5.2.0]壬-1(7)-烯-2-基)烷基]膦酸衍生物及其作为n-甲基-d-天冬氨酸(nmda)受体拮抗剂的应用 |
| WO2004089369A2 (en) * | 2003-04-11 | 2004-10-21 | Cambridge University Technical Services Limited | Methods and means for treating protein conformational disorders |
| US7485706B2 (en) * | 2003-07-30 | 2009-02-03 | The Board Of Trustees Of The Leland Stanford Junior University | Neurodegenerative protein aggregation inhibition methods and compounds |
| GT200400213A (es) | 2003-10-22 | 2007-09-05 | Metodos para la preparacion del acido {2-[(8,9)-dioxo-2,6-diaza-biciclo[5.2.0]-non-1(7)-en-2-il]etil} fosfonico y esteres del mismo | |
| RU2007119585A (ru) | 2004-12-20 | 2009-01-27 | Вайет (Us) | Производные рапамицина и их применение при лечении неврологических заболеваний |
| WO2006068932A2 (en) * | 2004-12-20 | 2006-06-29 | Wyeth | Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders |
| JP4857071B2 (ja) * | 2006-10-12 | 2012-01-18 | 潤平 笹部 | 筋萎縮性側策硬化症（ａｌｓ）の検出方法 |
| EP2065038A1 (en) | 2007-11-30 | 2009-06-03 | Pharnext | New therapeutic approaches for treating Charcot-Marie-Tooth disease |
| EP2135607A1 (en) | 2008-06-18 | 2009-12-23 | Pharnext | Combination of pilocarpin and methimazol for treating Charcot-MarieTooth disease and related disorders |
| AU2010233073B2 (en) * | 2009-04-10 | 2014-07-31 | Haiyan Qi | Novel anti-aging agents and methods to identify them |
| EP2263665A1 (en) | 2009-06-02 | 2010-12-22 | Pharnext | New compositions for treating CMT and related disorders |
| US9393241B2 (en) | 2009-06-02 | 2016-07-19 | Pharnext | Compositions for treating CMT and related disorders |
| US20120122913A1 (en) * | 2009-07-24 | 2012-05-17 | Institut National De La Recherche Scientifque | Combination of curcuminoids and mtor inhibitors for the treatment of tauopathies |
| US9283211B1 (en) | 2009-11-11 | 2016-03-15 | Rapamycin Holdings, Llc | Oral rapamycin preparation and use for stomatitis |
| US9121859B2 (en) * | 2012-12-04 | 2015-09-01 | Siemens Healthcare Diagnostics Inc. | Compounds and methods for determination of FKBP-binding immunosuppressant drugs |
| LT3003268T (lt) | 2013-06-05 | 2018-12-10 | Pharnext | Stabilūs peroraliniai tirpalai, skirti kompleksiniam aktyviam farmaciniam ingredientui (api) |
| US9700544B2 (en) | 2013-12-31 | 2017-07-11 | Neal K Vail | Oral rapamycin nanoparticle preparations |
| US10383870B2 (en) | 2016-06-10 | 2019-08-20 | Pharnext | Early treatment of CMT disease |
| US20200354445A1 (en) * | 2017-11-15 | 2020-11-12 | Vanderbilt University | Methods and compositions for the improvement of lysosomal function and treatment of neurodegenerative disease |
| CN114366738A (zh) * | 2021-12-20 | 2022-04-19 | 中国人民解放军军事科学院军事医学研究院 | 雷帕霉素在促进神经干细胞扩增中的用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5206018A (en) * | 1978-11-03 | 1993-04-27 | Ayerst, Mckenna & Harrison, Inc. | Use of rapamycin in treatment of tumors |
| JPH04230389A (ja) * | 1990-07-16 | 1992-08-19 | American Home Prod Corp | ラパマイシン誘導体 |
| US5078999A (en) * | 1991-02-22 | 1992-01-07 | American Home Products Corporation | Method of treating systemic lupus erythematosus |
| IL101353A0 (en) * | 1991-04-03 | 1992-11-15 | American Home Prod | Pharmaceutical compositions for treating diabetes |
| DE4118740A1 (de) * | 1991-06-05 | 1992-12-10 | Schering Ag | Neue kombinationspraeparate zur behandlung des morbus parkinson |
| IL102414A (en) * | 1991-07-25 | 1996-08-04 | Univ Louisville Res Found | Medicinal preparations for the treatment of ocular inflammation, containing rapamycin |
| US5260299A (en) * | 1992-03-05 | 1993-11-09 | American Home Products Corporation | Rapamycin 42-sulfonates and 42-(N-Carboalkoxy)Sulfamates Useful as Immunosuppressive Agents |
| IL111003A0 (en) * | 1993-09-30 | 1994-11-28 | American Home Prod | Multi-component oral rapamycin formulation |
-
1996
- 1996-11-28 TW TW085114700A patent/TW427904B/zh not_active IP Right Cessation
- 1996-12-04 DK DK96308786T patent/DK0778023T3/da active
- 1996-12-04 SI SI9630586T patent/SI0778023T1/xx unknown
- 1996-12-04 AT AT96308786T patent/ATE234095T1/de not_active IP Right Cessation
- 1996-12-04 DE DE69626610T patent/DE69626610T2/de not_active Expired - Fee Related
- 1996-12-04 ES ES96308786T patent/ES2188730T3/es not_active Expired - Lifetime
- 1996-12-04 PT PT96308786T patent/PT778023E/pt unknown
- 1996-12-04 SK SK1547-96A patent/SK154796A3/sk unknown
- 1996-12-04 CZ CZ9864A patent/CZ6498A3/cs unknown
- 1996-12-04 EP EP96308786A patent/EP0778023B1/en not_active Expired - Lifetime
- 1996-12-04 CZ CZ963544A patent/CZ354496A3/cs unknown
- 1996-12-05 KR KR1019960062011A patent/KR970032856A/ko not_active Application Discontinuation
- 1996-12-05 ZA ZA9610245A patent/ZA9610245B/xx unknown
- 1996-12-05 NZ NZ299888A patent/NZ299888A/en unknown
- 1996-12-05 MX MX9606131A patent/MX9606131A/es unknown
- 1996-12-05 AU AU74178/96A patent/AU700653B2/en not_active Ceased
- 1996-12-06 CN CN96123098A patent/CN1112925C/zh not_active Expired - Fee Related
- 1996-12-06 IL IL11977896A patent/IL119778A/xx not_active IP Right Cessation
- 1996-12-06 NO NO965238A patent/NO309966B1/no not_active IP Right Cessation
- 1996-12-06 BR BR9605895A patent/BR9605895A/pt not_active Application Discontinuation
- 1996-12-06 HU HU9603370A patent/HUP9603370A3/hu unknown
- 1996-12-06 CA CA002192298A patent/CA2192298A1/en not_active Abandoned
- 1996-12-06 JP JP8326582A patent/JPH09183727A/ja active Pending
- 1996-12-06 AR ARP960105543A patent/AR008747A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MX9606131A (es) | 1997-08-30 |
| AU700653B2 (en) | 1999-01-14 |
| SI0778023T1 (en) | 2003-08-31 |
| CZ6498A3 (cs) | 1998-06-17 |
| SK154796A3 (en) | 1997-09-10 |
| DE69626610T2 (de) | 2003-10-02 |
| AU7417896A (en) | 1997-06-12 |
| DE69626610D1 (de) | 2003-04-17 |
| EP0778023A1 (en) | 1997-06-11 |
| IL119778A0 (en) | 1997-03-18 |
| HU9603370D0 (en) | 1997-01-28 |
| ZA9610245B (en) | 1998-06-05 |
| CA2192298A1 (en) | 1997-06-08 |
| NO965238L (no) | 1997-06-09 |
| NZ299888A (en) | 2001-02-23 |
| CZ354496A3 (cs) | 1998-03-18 |
| EP0778023B1 (en) | 2003-03-12 |
| NO309966B1 (no) | 2001-04-30 |
| PT778023E (pt) | 2003-06-30 |
| ES2188730T3 (es) | 2003-07-01 |
| HUP9603370A2 (en) | 1997-05-28 |
| HUP9603370A3 (en) | 1998-12-28 |
| ATE234095T1 (de) | 2003-03-15 |
| KR970032856A (ko) | 1997-07-22 |
| AR008747A1 (es) | 2000-02-23 |
| CN1112925C (zh) | 2003-07-02 |
| CN1159915A (zh) | 1997-09-24 |
| TW427904B (en) | 2001-04-01 |
| JPH09183727A (ja) | 1997-07-15 |
| DK0778023T3 (da) | 2003-06-30 |
| NO965238D0 (no) | 1996-12-06 |
| BR9605895A (pt) | 1998-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL119778A (en) | Neuropretective pharmaceutical compositions containing rapamycin derivatives | |
| NZ304982A (en) | Pyridinyloxy- or pyridinylamino-acetamide derivatives; pharmaceutical compositions | |
| HU228234B1 (en) | Rapamycin derivatives, pharmaceutical compositions containing them and their use | |
| HUP9900391A3 (en) | Pharmaceutical compositions containing rapamycins | |
| IL116851A (en) | 3-arylidene-2-oxindole derivatives and pharmaceutical compositions containing them | |
| GR3032486T3 (en) | 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol derivatives as pharmaceutical agents | |
| HK1002384A1 (en) | Pharmaceutical compositions containing irbesartan | |
| HUP9802999A3 (en) | Pharmaceutical composition containing n-propargyl-1-aminoindan | |
| IL111007A0 (en) | Composition containing rapamycin for oral administration | |
| AU6613996A (en) | Heterocyclic compounds and pharmaceutical compositions containing them | |
| HUP0000979A3 (en) | Pharmaceutical compositions containing fk-506 and derivatives thereof | |
| ZA967827B (en) | Pharmaceutical compositions | |
| HUP9802290A3 (en) | Pyrrole derivatives and pharmaceutical compositions containing them | |
| HUP9602196A2 (en) | Sulfonyl- and sulfinyl-benzoyl-guanidine derivatives and pharmaceutical compositions thereof | |
| EG24294A (en) | Pharmaceutical compositions | |
| GB9506382D0 (en) | Pharmaceutical compositions | |
| GB9513972D0 (en) | Pharmaceutical compositions | |
| ZA9710919B (en) | Pharmaceutical compositions containing N-sulphony-lindole derivatives | |
| GB9502695D0 (en) | Pharmaceutical composition | |
| HUP9802291A3 (en) | Penicillaminamide derivatives and pharmaceutical compositions containing them | |
| HUP9602223A3 (en) | Biotin derivatives and pharmaceutical compositions containing them | |
| AU3710695A (en) | Quinolonylcarboxyerythromycin derivatives and pharmaceutical compositions containing them | |
| IL117618A0 (en) | Diphenylmethyl-azetidinone derivatives and pharmaceutical compositions containing the same | |
| IL117090A (en) | Pharmaceutical compositions containing oxazolidinone derivatives | |
| IL117155A0 (en) | Quinolizinone derivatives and pharmaceutical compositions containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| FF | Patent granted | ||
| HCA | Change of name of proprietor(s) after amalgamation | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |